HC upholds validity of Bihar pharmacist rules

Patna:  The Patna high court on Thursday upheld the constitutional validity of the Bihar Pharmacists Cadre (Amendment) Rules, 2014, which prescribe a diploma in pharmacy (D.Pharma) as the minimum educational qualification for the direct recruitment of pharmacists in the state.

A division bench comprising Acting Chief Justice Ashutosh Kumar and Justice Partha Sarthy delivered the judgement while disposing of a batch of writ petitions filed by Sanjeev Kumar Mishra and 120 other petitioners.

The bench, while appreciating the submissions of advocate general P K Shahi, held that the state govt is legally competent to frame rules prescribing a minimum educational qualification suited to its healthcare infrastructure.
The court noted that a diploma in pharmacy includes 500 hours of intensive hospital training and practical duties. It observed that determining the necessity of such training for the appointment of pharmacists falls within the executive wisdom of the state govt and the high court would not interfere with such policy decisions.

The court further held that the requirement of a diploma as an essential qualification is neither arbitrary nor discriminatory towards candidates holding higher degrees such as a bachelor or master in pharmacy. It clarified that the state’s pharmacists cadre rules provide an avenue for such candidates to be considered, provided they also hold a D. Pharma qualification.

The court also ruled that the Bihar Pharmacists Cadre Rules, 2014, do not contravene the directives of the Pharmacy Council of India (PCI), the central regulatory authority for the pharmacy profession.
Senior advocates Yadu Vansh Giri, Satyadarshi Sanjay, Mrigank Mauli, Abhinav Srivastav, Md Mumtaz Uddin and Prashant Sinha argued the case on behalf of the petitioners. Advocate general P K Shahi represented the state. Senior advocate Jitendra Singh appeared on behalf of the Pharmacy Council of India while senior advocate Lalit Kishore represented aspirants who had intervened to oppose the writ petitions.

Related Posts

CDSCO declares 159 drug samples as NSQs in June

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 159 drug samples tested across the country during the month of June, 2026, as Not of…

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

The decision could hit India hard, as it is the largest exporter of generic drugs to the US. US President Donald Trump has announced steep tariffs on imported generic medicines,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO declares 159 drug samples as NSQs in June

CDSCO declares 159 drug samples as NSQs in June

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

Government takes steps to strengthen primary healthcare services

Government takes steps to strengthen primary healthcare services

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide